Located in a strategic area of Sri Lanka, this project presents an exclusive opportunity to invest in a state-of-the-art facility for manufacturing Dry Powder Injectables (Carbapenems). These life-saving antibiotics are in high global demand, creating a strong growth pathway within the pharmaceutical sector
Why Invest?
-
High-Demand Product: Carbapenems are critical antibiotics with rapidly expanding global markets.
-
De-Risked Investment: Backed by a 10-year government buy-back agreement, ensuring guaranteed offtake and revenue stability.
-
Attractive Returns: Estimated investment of USD 13 million with a payback period of only 3.3 years.
-
Exceptional Profitability: Conservative projections show an Internal Rate of Return (IRR) of up to 140%.
-
Strategic Location: Positioned to serve both domestic and international markets, with strong government support.
This project stands as one of the most promising pharmaceutical investment opportunities in Sri Lanka. Join us in shaping the future of healthcare while securing exceptional financial returns.
For more information – info@dprinvestments.lk
